Intelligence · Clinical Development
Pipeline search results
Programs matching “autologous” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 59 pipeline programs matching "autologous" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
GARM-Autism Adults
Blackmores Limited
Autism Spectrum Disorder
1 trial -
Infusion of autologous mononuclear bone marrow cells
Lxo Ireland Designated Activity Company
Idiopathic Dilated Cardiomyopathy
1 trial -
Intraarterial infusion of autologous bone marrow cells
Lxo Ireland Designated Activity Company
Critical Limb Ischemia (CLI)
2 trials -
Intracavernosal administration of autologous ADRC
The First People's Hospital of Lianyungang
Erectile Dysfunction
1 trial -
Intracoronary infusion of autologous bone marrow cells
Lxo Ireland Designated Activity Company
Dilated Cardiomyopathy
1 trial -
LIMBAL STEM CELLS, AUTOLOGOUS
Fondazione Telethon ETS
low back pain
1 trial -
LZRSE-Col7A1 Engineered Autologous Epidermal Sheets
ABEONA THERAPEUTICS INC.
Epidermolysis Bullosa Dystrophica
1 trial -
Suspension of autologous mononuclear cells separated from bone marrow aspirate
The George Institute
chronic limb-threatening ischemia, diabetic foot ulcers
1 trial -
Transplantation of Autologous stem cell [MNCs] .
Hospital Authority, Hong Kong
Spinal Cord Injury.
1 trial -
autologous adipose-derived mesenchymal stem cell transplantation
Hospital Authority, Hong Kong
Aging Problems
1 trial -
autologous anti-BCMA chimeric antigen receptor T cells
The First People's Hospital of Lianyungang
ITP
1 trial -
autologous dendritic cells pulsed with tumor lysate antigen Vaccine
NORTHWEST BIOTHERAPEUTICS INC
Giant Cell Glioblastoma
1 trial -
autologous mesenchymal stem cells implantation
Teva Pharma GmbH
Tibial Fracture
1 trial -
autologous skin fibroblasts
United Therapeutics Europe Ltd
Wounds and Injuries
1 trial -
idecabtagene vicleucel
Celgene Europe Limited
Relapsed and refractory multiple myeloma (RRMM), multiple myeloma (MM) with progression within 18 months of initial treatment/ or newly diagnosed multiple myeloma (NDMM) with suboptimal response post autologous stem cell transplant (ASCT) (Cohort 3 only)
1 trial -
therapeutic autologous dendritic cells
LISATA THERAPEUTICS, INC.
Melanoma (Skin)
1 trial -
Autologous Bone Marrow-derived Mononuclear Cells
Regeneron Ireland Designated Activity Company (DAC)
Congenital Heart Disease
1 trial -
Autologous Engineered Urethral Construct
United Therapeutics Europe Ltd
Urologic Diseases
1 trial -
Autologous Human Schwann Cell
United Therapeutics Europe Ltd
Peripheral Nerve Injury
1 trial -
Autologous Natural Killer Cell Therapy
Hospital Authority, Hong Kong
Hepatocellular Carcinoma
1 trial -
Autologous differentiated myocyte transplantation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metabolic Disease
1 trial -
Autologous mononuclear cells
Regeneron Ireland Designated Activity Company (DAC)
Congenital Heart Disease, SRV Dependent
1 trial -
Autologous tissue engineered corpora
United Therapeutics Europe Ltd
Urologic Diseases
1 trial -
Autologous tumor-infiltrating lymphocyte cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Solid Tumor
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.